Compare
Charles River Laboratories vs Danaher (CRL vs DHR)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Charles River Laboratories (CRL) returned +101.3% and Danaher (DHR) +8.5%; so far this year the figures are +69.2% and +0.6%.
Danaher is the larger company by market value, about 10.0 times the size of Charles River Laboratories.
On trailing earnings, CRL trades at 348.0 times and DHR at 37.7 times.
Revenue grew -1.2% at CRL and +5.5% at DHR over the last year.
CRL pays no dividend. DHR yields 0.66%.
Data as of the latest close. Not investment advice.
Relative performance
| CRL | DHR | |
|---|---|---|
| Price | $337.52 | $230.25 |
| 1-day | +7.83% | +1.73% |
| YTD | +69.20% | +0.58% |
| 1 year | +101.26% | +8.50% |
| 3 years | +101.48% | +21.18% |
| Market cap | $16.2B | $162.0B |
| P/E | 348.0 | 37.7 |
| P/S | 4.07 | 6.33 |
| P/B | 5.01 | 3.02 |
| Revenue growth | -1.20% | +5.50% |
| EPS growth | — | +26.00% |
| Gross margin % | 39.4 | 58.6 |
| Net margin % | 1.0 | 16.9 |
| ROE % | 1.2 | 8.1 |
| Debt / equity | 0.76 | 0.49 |
| FCF yield % | 2.5 | 3.5 |
| Dividend yield % | — | 0.66 |
| Beta | 1.24 | 0.53 |
| RSI (14) | 53.7 | 53.5 |
| Technical rating |